PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
04-Dec-2019 Volker Koscielny, new Chief Medical Officer and new member of the Management Board at Almirall Almirall
04-Dec-2019 First UK Clinical Trial Site Open for Recruitment of Diabetic Patients with Chronic Limb-Threatening Ischemia Using Novel Patient-Specific Regenerative Cell Therapy The University Hospital of Wales
04-Dec-2019 Interview Released Stefan Przyborski, Chairman for SMi’s 3D Cell Culture Conference 2020 SMi Group
04-Dec-2019 Phoenix Solutions AS Strengthens Its Board With the Appointment of Dr. Jean-Michel Cosséry Phoenix Solutions AS
04-Dec-2019 Chiesi outlines €350 million investment and announces the development of the first carbon minimal pressurised Metered Dose Inhaler (pMDI) for Asthma and COPD Chiesi Group
04-Dec-2019 Kancera reports in-depth analysis of the Phase Ib program with KAND567, showing the desired effect on the human immune system Kancera AB
04-Dec-2019 MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs MaxCyte, Inc.
04-Dec-2019 MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs MaxCyte
04-Dec-2019 Panel Discussion on ‘Deep Dive Shortages: The Impact on Patient Safety’ to be held at Parallel Trade 2020 SMi Group
04-Dec-2019 Ashfield announces appointment of two new global presidents Ashfield
03-Dec-2019 Cancer – New Inhibitor Effective Where Others Fail Karl Landsteiner University of Health Sciences
03-Dec-2019 Announces Distribution Agreement with Apex Ascension Healthcare plc
03-Dec-2019 ASLAN PHARMACEUTICALS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES ASLAN Pharmaceuticals
02-Dec-2019 Confo Therapeutics reports grant of two key patents for ConfoBodies™ Confo Therapeutics
02-Dec-2019 Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop Destiny Pharma plc
02-Dec-2019 Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies Cambridge Innovation Capital
02-Dec-2019 Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer Ergomed plc
02-Dec-2019 ABPI appoints Dr Richard Torbett as new Chief Executive The Association of the British Pharmaceutical Industry (ABPI)
02-Dec-2019 Elucid Health achieves 100% robustness in ongoing trials of their Pill Connect smart pill bottle that could help improve adherence to medications Elucid Health
02-Dec-2019 NICE EXPANDS RECOMMENDATION FOR LYNPARZATM (OLAPARIB) TABLETS FOR WOMEN WITH RELAPSED, BRCA-MUTATED, ADVANCED OVARIAN CANCER[I] AstraZeneca